Search Library
Therapeutic Areas
Management
Resource Type
Setting
Quality Improvement Topics
EP Preprocedure Site Prep One-Pager
Checklists: UW Health Nursing One Pager – Electrophysiology Procedure Site Preparation
Paroxysmal Atrial Fibrillation/Atrial Flutter with RVR ED Pathway
Care Pathways/CDS: Paroxysmal Atrial Fibrillation/Atrial Flutter with RVR ED Pathway
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines
Guidelines/Clinical Documents: Atrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally. Recommendations from the “2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” and the “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation” have been updated with new evidence to guide clinicians. In addition, new recommendations addressing atrial fibrillation and thromboembolic risk assessment, anticoagulation, left atrial appendage occlusion, atrial fibrillation catheter or surgical ablation, and risk factor modification and atrial fibrillation prevention have been developed.
Virtual Atrial Fibrillation Center Model: An Effective New Strategy for the Management of Patients With Atrial Fibrillation
Journal Articles: Virtual Atrial Fibrillation Center Model: An Effective New Strategy for the Management of Patients With Atrial Fibrillation
Clinic Time Required for Remote and In-Person Management of Patients With Cardiac Devices: Time and Motion Workflow Evaluation
Workflows: This study aims to characterize the workflow and quantify clinic staff time requirements for managing patients with CIEDs.
FDA and Device Regulation
Presentations and Graphics: In this slideshow presentation, the learner will explore the mission and history of the FDA and Center for Device and Radiological Health (CDRH), how the CDRH and FDA contribute to a device’s classification, approval, and post-approval maintenance, and an overview of the Total Product Lifecycle Advisory Program Pilot.
FDA Medical Device Advisory Committee Presentation
Presentations and Graphics: In this presentation, the learner will explore the purpose and structure of a medical device advisory committee, how they function, and recent guidance.
FDA Collaborative Communities and Early Feasibility Studies
Presentations and Graphics: Slideshow presentation that explores collaborative communities, early feasibility studies, and the EP EFS initiative.
FDA Investigational Device Exemptions IDE and IRBs
Presentations and Graphics: Slideshow presentation that explore what an investigational device exemption is, significant risk versus non-significant risk device studies, and how IRB’s and the FDA factor in to decisions around device studies.
Distinguishing Research from Quality Improvement
Presentations and Graphics: Research and Quality Improvement activities are different, with a small degree of overlap. This table resource defines some of the differences.